10x Genomics Expands Leadership in Single Cell Analysis with Launch of GEM-X Technology

GEM-X, the next generation of the company's leading single cell technology architecture, enables higher performance at larger scale and lower cost
Pre-orders now open for first two Chromium products...

Related Keywords

,Michael Schnall Levin ,Securities Exchange ,Nasdaq ,Exchange Commission ,Linkedin ,Genomics Inc ,Founding Scientist ,Chief Technology Officer ,Chromium Single Cell Gene Expression ,Chromium Single Cell Immune Profiling ,Chromiumx Series ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Financial Condition ,Markets ,